Atlas Trials

CANBESURE STUDY (Cancer, Bemiparin and Surgery Evaluation)

Clinical trial NCT00219973 · COMPLETED

Trial details

NCT number
NCT00219973
Sponsor
Rovi Pharmaceuticals Laboratories
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
CancerVenous Thromboembolism
Start date
2005-05-01
Enrollment
526

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.